VISTAGEN THERAPEUTICS, INC. (VTGN) Operating income 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) annual operating income history from SEC filings — each fiscal year as reported.
-$72.1MFY2026 · since FY2017: -$10.2M → -$72.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$72.1M | -28.9% |
| FY2025 | -$56.0M | -69.5% |
| FY2024 | -$33.0M | +44.3% |
| FY2023 | -$59.3M | -24.0% |
| FY2022 | -$47.8M | -166.4% |
| FY2021 | -$17.9M | +13.8% |
| FY2020 | -$20.8M | +15.3% |
| FY2019 | -$24.6M | -72.9% |
| FY2018 | -$14.2M | -38.6% |
| FY2017 | -$10.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice